Exhibitors Search
INSPHARMTECH
Booth no.
E41
| Exhibition | PARTNERING |
|---|---|
| Country | Korea, South |
| Address | 1 Kangwondaehak-gil, Chuncheon-si, Gangwon-do, Republic of Korea |
| Tel (Rep.) | 02-854-1310 |
| Website | http://inspharmtech.com |
Company Introduction
Inspharmtech, Inc. is a biopharmaceutical company that develops first-in-class small-molecule therapeutics for age-related diseases, such as age-related macular degeneration and osteoarthritis. based on disease-oriented drug screening, sustained drug delivery, and PK/PD modeling technologies. In addition, we are developing probiotic-based exosomes as a cosmeceutical for whitening and skin inflammation.
Promotional video
Exhibit Item
Small molecule-based Long-Acting Macular Degeneration Therapeutics, Disease Modifying Osteoarthritis Drugs, Probiotics Exosome-based Cosmeceutical
Exhibit Item Images
-
Product Name : Small molecule-based Long-Acting Macular Degeneration Therapeutics, Disease Modifying Osteoarthritis Drugs, Probiotics Exosome-based CosmeceuticalSmall molecule-based Long-Acting Macular Degeneration Therapeutics, Disease Modifying Osteoarthritis Drugs, Probiotics Exosome-based Cosmeceutical
Exhibit Description
1. Biodegradable implants loaded with IPT012 are being developed as a long-acting therapeutic for age-related macular degeneration.
2. IPT015 is being developed as a disease-modifying osteoarthritis drug (DMOAD) with both SC and long-acting formulations.
3. IPT-Exo, an exosome derived from probiotics, has whitening and anti-inflammatory effects.
2. IPT015 is being developed as a disease-modifying osteoarthritis drug (DMOAD) with both SC and long-acting formulations.
3. IPT-Exo, an exosome derived from probiotics, has whitening and anti-inflammatory effects.
Co-Exhibitor or
Partner’s Information
| Company Name | Country |
|---|---|
KYUNGYON EXHIBITION CORP.